Literature DB >> 21529775

Clarithromycin, as an adjunct to non surgical periodontal therapy for chronic periodontitis: a double blinded, placebo controlled, randomized clinical trial.

A R Pradeep1, Rahul Kathariya.   

Abstract

OBJECTIVE: Along with conventional non-surgical periodontal therapy (NSPT) systemic antimicrobials may provide more effective treatment for chronic periodontitis by targeting tissue-invasive bacteria. The aim of this randomized, placebo-controlled, double-masked clinical trial was to evaluate the adjunctive effects of oral clarithromycin (CLM) to non-surgical periodontal therapy for chronic periodontitis.
METHODS: 40 patients were categorized into two groups: test group - scaling and root planing (SRP) plus CLM (500 mg b.i.d. for 3 days) and control group - SRP plus placebo. Clinical parameters were recorded at baseline and at 1, 3, 6, and 9 months. They included gingival index (GI), probing depth (PD), and clinical attachment level (CAL). Also microbial analysis of dental plaque was done at baseline, 3 and 9 months to estimate the levels of periodontopathic organisms using polymerase chain reaction. ANOVA, Chi-square and Bonferroni tests were used for statistical analysis.
RESULTS: Thirty-seven subjects completed the study and the results demonstrated that both groups displayed clinical improvements. Using a subject-based analysis, patients treated with SRP+CLM showed enhanced reductions in PD and gains in CAL (p<0.001) over time, as compared to control group. Also significant reductions in periodontopathic organisms were noticed in the test group compared to control group. However, no statistically significant differences were noted for Tannerella forsythia levels between the groups during the course of the study.
CONCLUSIONS: The utilisation of CLM in combination with SRP improves the efficacy of NSPT in reducing PD, improving CAL and in lessening microbial loads. Hence, CLM may be beneficial in the non-surgical treatment regimen of chronic periodontitis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529775     DOI: 10.1016/j.archoralbio.2011.03.021

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  7 in total

1.  Azithromycin enhances phagocytic killing of Aggregatibacter actinomycetemcomitans Y4 by human neutrophils.

Authors:  Pin-Chuang Lai; Mark R Schibler; John D Walters
Journal:  J Periodontol       Date:  2015-01       Impact factor: 6.993

2.  [Efficacy of clarithromycin in the adjuvant treatment of chronic periodontitis: a Meta-analysis].

Authors:  Yin Bai; Yuan-Liang Bai; Jing Lai; Jiao Huang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-06-01

3.  Adverse events in people taking macrolide antibiotics versus placebo for any indication.

Authors:  Malene Plejdrup Hansen; Anna M Scott; Amanda McCullough; Sarah Thorning; Jeffrey K Aronson; Elaine M Beller; Paul P Glasziou; Tammy C Hoffmann; Justin Clark; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-18

4.  Unusual Findings in Trials Evaluating Adjuncts to Scaling and Root Planing: Reporting Quality (Part 2).

Authors:  K Al-Abedalla; J C Gunsolley; M Shaqman; E Ioannidou
Journal:  JDR Clin Trans Res       Date:  2021-10-05

5.  Evaluating the effectiveness of clarithromycin as an adjunct to scaling and root planing: A randomized clinical trial.

Authors:  Jammula Suryaprasanna; Potini Lakshmi Radhika; Parupalli Karunakar; Koduganti Rekharani; Umrana Faizuddin; Mallela George Manojkumar; Suribabu Jammula
Journal:  J Indian Soc Periodontol       Date:  2018 Nov-Dec

Review 6.  Porphyromonas gingivalis: where do we stand in our battle against this oral pathogen?

Authors:  Kaitlind C Howard; Octavio A Gonzalez; Sylvie Garneau-Tsodikova
Journal:  RSC Med Chem       Date:  2021-02-26

7.  Adjunctive systemic antimicrobials for the non-surgical treatment of periodontitis.

Authors:  Shivi Khattri; Sumanth Kumbargere Nagraj; Ankita Arora; Prashanti Eachempati; Chandan Kumar Kusum; Kishore G Bhat; Trevor M Johnson; Giovanni Lodi
Journal:  Cochrane Database Syst Rev       Date:  2020-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.